Pleura and Peritoneum
Scope & Guideline
Empowering professionals through open-access insights.
Introduction
Aims and Scopes
- Focus on Peritoneal and Pleural Malignancies:
The journal primarily addresses the complexities associated with peritoneal and pleural cancers, including treatment methodologies, surgical interventions, and innovative therapeutic strategies. - Innovations in Chemotherapy Techniques:
A significant emphasis is placed on emerging chemotherapy techniques such as Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and Pressurized IntraThoracic Aerosol Chemotherapy (PITAC), showcasing their applications and outcomes in treating metastatic diseases. - Surgical Techniques and Outcomes:
Research published often explores various surgical techniques, including cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), focusing on their effectiveness and safety in managing peritoneal surface malignancies. - Clinical and Diagnostic Research:
The journal includes studies that investigate the diagnostic and prognostic factors related to pleural and peritoneal diseases, aiming to enhance clinical decision-making and patient management. - Patient-Centric Approaches:
There is a consistent focus on the quality of life, patient outcomes, and the implementation of enhanced recovery protocols in surgical oncology, reflecting a commitment to holistic patient care.
Trending and Emerging
- Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC):
PIPAC has become a prominent topic within the journal, reflecting its emerging role as a promising treatment for peritoneal metastasis, with numerous studies assessing its efficacy and safety. - Enhanced Recovery After Surgery (ERAS) Protocols:
There is an increasing focus on implementing ERAS protocols in surgical oncology, emphasizing the importance of improving recovery times and patient outcomes post-surgery. - Meta-Analysis and Systematic Reviews:
The journal is seeing a rise in meta-analyses and systematic reviews that synthesize existing data on surgical and chemotherapy techniques, providing comprehensive insights into treatment efficacy and safety. - Patient Quality of Life and Prognostic Factors:
Emerging themes include the assessment of quality of life and the identification of prognostic biomarkers, which are becoming crucial for tailoring treatment approaches and improving patient care. - Multicenter Trials and Collaborative Research:
An increase in multicenter trials and collaborative studies is evident, indicating a trend towards more extensive data collection and analysis to enhance the robustness of research findings.
Declining or Waning
- Traditional Chemotherapy Approaches:
Research related to traditional chemotherapy methods appears to be waning, as newer approaches like PIPAC gain traction, highlighting a shift towards more innovative and targeted therapies. - Basic Science Studies:
There seems to be a decrease in purely basic science studies that do not directly correlate with clinical applications. As the journal's focus sharpens on clinical and translational research, foundational studies may be less represented. - General Surgical Techniques:
Papers focusing on general surgical techniques without a specific connection to pleural or peritoneal conditions are becoming less common, as the journal prioritizes specialized surgical approaches that directly impact patient outcomes.
Similar Journals
Clinical Lymphoma Myeloma & Leukemia
Fostering Collaboration in Blood Cancer ScienceClinical Lymphoma Myeloma & Leukemia is a prestigious journal dedicated to the study and treatment of hematologic malignancies, offering a vital platform for researchers and healthcare professionals in the fields of oncology, hematology, and cancer research. Published by CIG MEDIA GROUP, LP, this journal has established itself as a crucial resource since its inception in 2010, with a continuous commitment to disseminating knowledge until at least 2024. With an impact factor that objectively reflects its influence, it is rated in Q3 quartiles in both Cancer Research and Hematology as well as in Oncology as of 2023. Researchers can access a wealth of articles and studies that explore various dimensions of lymphoma, myeloma, and leukemia, thus fostering an environment of collaboration and innovation. Although it currently does not offer full open access, its extensive archive and rigorous peer-review process ensure the publication of high-quality research, making it an essential resource for anyone dedicated to advancing the science and practice of treating blood cancers.
Indian Journal of Urology
Exploring Innovations in Urology for a Healthier Future.Indian Journal of Urology, published by Wolters Kluwer Medknow Publications, is a premier open-access journal dedicated to the field of urology, serving as a vital platform for researchers and clinicians to disseminate groundbreaking findings since its inception in 2001. With an ISSN of 0970-1591 and an E-ISSN of 1998-3824, this journal has established itself as a crucial resource for advancing knowledge in urological practices, particularly within the Indian context. Recognized in the 2023 Scopus Rankings with a classification of Q3 in Urology, it stands at a significant position (Rank #71 out of 120) with a 41st percentile performance, highlighting its role in contributing to the global discourse in urological medicine. The journal provides open access options, ensuring that high-quality research is readily available to a broad audience, fostering collaboration and innovation. Publishing significant studies from various converged years, including from 1984 to 1999 and more recently from 2006 to 2024, Indian Journal of Urology is essential for professionals seeking to stay updated with the latest advances and best practices in urology.
Clinical Genitourinary Cancer
Leading the charge in urological research excellence.Clinical Genitourinary Cancer, published by CIG MEDIA GROUP, LP, is a leading journal in the fields of Oncology and Urology, with an impressive impact reflected in its quartile rankings (Q2 in Oncology and Q1 in Urology for 2023) and strong Scopus rankings (22nd in Urology and 162nd in Oncology). The journal aims to innovate and inspire new research in genitourinary malignancies, providing a platform for the latest findings in diagnosis, treatment, and patient management. With its commitment to high-quality publications since its establishment in 2005, Clinical Genitourinary Cancer serves a crucial role in advancing the understanding of these complex conditions and enhancing clinical practices. Researchers, professionals, and students in the medical community are encouraged to engage with this essential resource, which facilitates open access to pioneering studies that drive the field forward.
CURRENT TREATMENT OPTIONS IN ONCOLOGY
Exploring the Latest in Cancer Therapies and TreatmentsCURRENT TREATMENT OPTIONS IN ONCOLOGY, published by Springer, is a premier academic journal dedicated to disseminating cutting-edge research and advancements in the field of oncology and pharmacology. With a commendable impact factor and ranked in the Q1 category in both oncology and pharmacology for 2023, this journal positions itself as a leading resource for researchers, healthcare professionals, and students alike, offering insightful reviews and original articles that critically evaluate treatment methodologies and clinical practices. Covering a wide scope of topics from early detection to innovative therapies, it fosters the translation of research findings into clinical applications. With its convergence years spanning from 2000 to 2024, CURRENT TREATMENT OPTIONS IN ONCOLOGY continues to be at the forefront of oncological research, providing a platform for scholars to explore the latest therapeutic options and improve patient outcomes. Highly regarded in the academic community, this journal is essential for anyone looking to stay informed about the dynamic landscape of cancer treatment.
PROSTATE
Elevating the standards of prostate care and research.PROSTATE is a premier, peer-reviewed journal published by Wiley, focusing on the critical fields of urology and oncology. With an established history since 1980 and a projected convergence through 2024, this influential journal serves as a vital resource for researchers, clinicians, and students alike. It holds a prestigious position in the academic landscape, classified in the Q1 category for Urology and Q2 in Oncology as of 2023, demonstrating its significant contribution to these disciplines. With a Scopus rank of #23 in Urology and #169 in Oncology, PROSTATE is pivotal for advancing knowledge and fostering innovation in prostate research, treatment, and overall male health. The journal aims to publish high-quality original articles, reviews, and clinical studies that address the complexities of prostate-related conditions, ultimately seeking to improve patient outcomes and propagate best practices in the medical community.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Transforming the landscape of head and neck research.HEAD AND NECK: JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, published by Wiley, is a leading academic journal dedicated to advancing the field of otorhinolaryngology. With an impressive impact factor and ranked #5 out of 123 in the field according to Scopus, this journal serves as a premier platform for researchers, clinicians, and students alike to share and gain insights into cutting-edge developments related to head and neck sciences. With publication spanning from 1989 to 2024, it enjoys a Q1 ranking in the otorhinolaryngology category, reflecting its high quality and significant contribution to the scientific community. The journal is crucial for those aiming to stay at the forefront of research and clinical practices in this highly specialized area. This combination of rigorous peer review and a focus on both practical and experimental studies make HEAD AND NECK an essential resource for anyone involved in the healthcare and research sectors pertaining to the head and neck.
Annals of Hepato-Biliary-Pancreatic Surgery
Elevating Surgical Excellence in Hepato-Biliary-Pancreatic CareAnnals of Hepato-Biliary-Pancreatic Surgery is a leading academic journal dedicated to the fields of hepatobiliary and pancreatic surgery, contributing essential research and clinical insights to enhance surgical practices and patient outcomes. Published by the Korean Association of Hepato-Biliary-Pancreatic Surgery (KAHBPS), this journal serves as a vital resource for researchers, clinicians, and healthcare professionals interested in the latest advancements and methodologies within this specialized area. With an ISSN of 2508-5778 and an E-ISSN of 2508-5859, the journal presents a platform for high-quality, peer-reviewed articles that focus on the management and surgical techniques for liver, biliary, and pancreatic disorders. Although it currently offers limited open access options, the journal has been recognized in the 2023 Scopus Ranks, reflecting its influence in the medical community, particularly with a Q3 designation in Gastroenterology and Surgery. By fostering academic dialogue, the Annals of Hepato-Biliary-Pancreatic Surgery plays a crucial role in shaping evidence-based practice, making it indispensable for those engaged in this dynamic and evolving field.
Bladder Cancer
Unveiling breakthroughs in bladder cancer management.Bladder Cancer, published by IOS PRESS, is a premier open access journal dedicated to advancing the field of oncology and urology, with a specific focus on bladder cancer research and treatment. Established in 2015 and continuing through to 2024, this journal aims to disseminate high-quality, peer-reviewed research that contributes to the understanding, diagnosis, and management of bladder cancer, a critical area of concern in urological oncology. With a robust publication record now encompassing open access since 2023, Bladder Cancer ensures accessibility to vital research for clinicians, researchers, and scholars worldwide. The journal's rankings in Scopus reflect its commitment to excellence, holding a Q3 category in both oncology and urology, with Scopus ranks of #78 in Urology and #285 in Oncology, showcasing its growing influence in the scientific community. By fostering dialogue and innovation, Bladder Cancer serves as an essential resource for those committed to improving patient outcomes in bladder oncology.
Iraqi Journal of Hematology
Exploring the Frontiers of Hematological ResearchIraqi Journal of Hematology is a prominent peer-reviewed open-access journal dedicated to advancing the field of hematology. Published by Wolters Kluwer Medknow Publications, this journal provides a platform for researchers, professionals, and students to share cutting-edge findings and developments in various aspects of hematology, including blood diseases, diagnostics, and innovative treatments. Since its transition to open access in 2016, the journal has significantly increased its reach, allowing for wider dissemination of critical research to a global audience. With an ISSN of 2072-8069 and an E-ISSN of 2543-2702, the Iraqi Journal of Hematology strives to adhere to the highest scholarly standards and plays a vital role in the ongoing discourse in hematological research. Researchers are encouraged to contribute to this essential resource for the scientific community, contributing to the advancement of knowledge that ultimately improves patient care and treatment outcomes.
Indian Journal of Surgical Oncology
Illuminating the Path of Surgical Oncology AdvancementThe Indian Journal of Surgical Oncology, published by SPRINGER INDIA, is a vital source of scholarly research and discourse in the fields of oncology and surgery. Since its inception in 2010, the journal has been dedicated to advancing the science and practice of surgical oncology, providing a platform for researchers, clinicians, and educators to disseminate their findings and insights. With an increasing impact factor, the journal currently ranks in the Q4 category in Oncology and Q3 category in Surgery, reflecting its growing influence in the academic community. The journal maintains a focus on high-quality research, clinical studies, and innovative surgical techniques, fostering knowledge exchange among professionals in India and beyond. Although an open access option is not provided, the journal remains an essential repository of information for anyone engaged in the rapidly evolving fields of surgical oncology. For access to groundbreaking research and updates in the discipline, the Indian Journal of Surgical Oncology continues to be an indispensable resource.